Lifecore Biomedical GAAP EPS of -$0.16, revenue of $35.75M

* Lifecore Biomedical press release [https://seekingalpha.com/pr/20438291-lifecore-biomedical-reports-financial-results-for-the-fourth-quarter-and-transition-period] (LFCR [https://seekingalpha.com/symbol/LFCR]): Q4 GAAP EPS of -$0.16.
* Revenue of $35.75M (+9.8% Y/Y).

MORE ON LIFECORE BIOMEDICAL

* Lifecore Biomedical: Wins Should Blow Previous 'New Business' Estimates Out Of The Water [https://seekingalpha.com/article/4859539-lifecore-biomedical-wins-should-blow-previous-new-business-estimates-out-of-the-water]
* Lifecore Biomedical: The Turnaround Is Just Getting Started [https://seekingalpha.com/article/4856692-lifecore-biomedical-the-turnaround-is-just-getting-started]
* Quant snapshot: Micron, Babcock & Wilcox lead strong buys as Fold Holdings, Alvotech lag [https://seekingalpha.com/news/4563909-quant-snapshot-micron-babcock-wilcox-lead-strong-buys-as-fold-holdings-alvotech-lag]
* Seeking Alpha’s Quant Rating on Lifecore Biomedical [https://seekingalpha.com/symbol/LFCR/ratings/quant-ratings]
* Historical earnings data for Lifecore Biomedical [https://seekingalpha.com/symbol/LFCR/earnings]